Julio Rosenstock, MD, FACE Featured on ADA Diabetes Core Update Podcast

Julio Rosenstock, MD, FACE, joined the American Diabetes Association’s Diabetes Core Update podcast to discuss propound results from a recently published JAMA article, “Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes.” The study indicated that once weekly tirzepatide with insulin glargine may have the potential to change the standard of care for adults with type 2 diabetes taking basal insulin.

Additionally, Dr. Rosenstock was interviewed in several recent episodes about publications in JAMA, The Lancet, and the New England Journal of Medicine.

Listen here: https://diabetesjournals.org/journals/pages/diabetes-core-update-podcasts


Posted in

Quality. Continuity. Velocity.